IMC Chicago’s Arvinas ARVN Stock Holding History

IMC Chicago’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,219	Closed	-$374K	–	5697
2025 Q4	$358K	Buy	+30,219	New	+$330K	﹤0.01%	3696
2025 Q3	–	Sell	-40,403	Closed	-$306K	–	3589
2025 Q2	$297K	Buy	40,403 +9,058	+29%	+$66.7K	﹤0.01%	3112
2025 Q1	$220K	Buy	+31,345	New	+$491K	﹤0.01%	3032

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IMC Chicago's ARVN Position: Q1 2026 in Review

IMC Chicago sold out of Arvinas (ARVN) in Q1 2026, closing a stake of 30,219 shares — an estimated $374K sold.

IMC Chicago first reported a position in ARVN in Q1 2025 and held it in 3 quarters. The position peaked at $358K in Q4 2025. 207 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

IMC Chicago reported no remaining Arvinas position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 30,219 Arvinas shares in Q1 2026, an estimated $374K.
IMC Chicago first reported a position in Arvinas in Q1 2025 and held it in 3 quarters.
IMC Chicago's Arvinas position peaked at $358K in Q4 2025.
207 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.